Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for prevention and treatment of emergence agitation after sevoflurane anesthesia
ChiCTR2500110857Phase 4Completed
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Emergence agitation (EA) (3 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoint: Riker Sedation-Agitation Scale. Started Oct 2025; status: completed.
02
Drugs
remimazolam
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2500110857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110857.